Blueshift Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
4,800
+2,376
+98% +$288K 0.12% 202
2026
Q1
$396K Sell
2,424
-244
-9% -$37.5K 0.12% 266
2025
Q4
$464K Buy
2,668
+557
+26% +$102K 0.13% 232
2025
Q3
$304K Buy
+2,111
New +$259K 0.09% 303
2024
Q4
Sell
-4,997
Closed -$365K 437
2024
Q3
$365K Buy
+4,997
New +$369K 0.09% 245
2022
Q1
Sell
-8,955
Closed -$244K 980
2021
Q4
$244K Buy
+8,955
New +$256K 0.02% 700
2021
Q3
Sell
-23,183
Closed -$660K 1140
2021
Q2
$660K Buy
+23,183
New +$688K 0.04% 472
2021
Q1
Sell
-6,207
Closed -$207K 954
2020
Q4
$207K Buy
+6,207
New +$227K 0.02% 615

Other funds holding INSM

Blueshift Asset Management's INSM Position: Q2 2026 in Review

Blueshift Asset Management increased its Insmed (INSM) stake by 98% in Q2 2026, buying an estimated $288K and bringing the position to 4,800 shares worth $512K. The position accounts for 0.12% of the portfolio, ranked #202.

Blueshift Asset Management first reported a position in INSM in Q4 2020 and has held it in 8 quarters since. The position peaked at $660K in Q2 2021. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Blueshift Asset Management held 4,800 shares of Insmed worth $512K as of Q2 2026.
  • Blueshift Asset Management bought 2,376 Insmed shares in Q2 2026, an estimated $288K.
  • Insmed made up 0.12% of Blueshift Asset Management's portfolio in Q2 2026, its #202 holding.
  • Blueshift Asset Management first reported a position in Insmed in Q4 2020 and has held it in 8 quarters since.
  • Blueshift Asset Management's Insmed position peaked at $660K in Q2 2021.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.